TNG
Thymus Nuclear Glycoprotein (TNG)* is a a drug compound made for the treatment of the HIV-1/AIDS infection. Under the lawful order of the Republic of Bulgaria, TNG has completed Phase III, which is comprised of a clinical trial conducted in Specialized Hospital for Active Treatment of Infectious and Parasitic Deceases “Professor Ivan Kirov”, Sofia on 20 patients suffering from AIDS in the advanced stages of the disease. The results of the clinical trial can be summarized as follows:
General decrease in the viral load and general increase in the number of CD4+ cells.
No unwelcome medical reactions and unwanted events.
Total absence of toxicity in comparison to contemporary antiretrovial remedies.
Substantial improvement of the general condition and lack of opportunistic infections in almost all patients.
Easy short-term application that does not require hospitalization.
These results show that TNG has a significant place in the treatment of HIV. We have reasons to believe that TNG cures AIDS in depth, meaning not solely in the blood stream, but also in the depots, the lymph and on DNA level.
*TNG is the name, as clinically tested and designated in the exclusive rights for production and distribution. Actual trading name of the product to follow.
** All images are with illustrative purpose only and do not show the actual product.
*** TNG is not FDA approved.